Kinsale Capital Group Inc is an insurance-property & casualty business based in the US. Kinsale Capital Group shares (KNSL) are listed on the NYSE and all prices are listed in US Dollars. Kinsale Capital Group employs 364 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $236.14 |
|---|---|
| 52-week range | $157.54 - $244.87 |
| 50-day moving average | $218.50 |
| 200-day moving average | $206.10 |
| Wall St. target price | $283.33 |
| PE ratio | 34.7413 |
| Dividend yield | $0.46 (0.23%) |
| Earnings per share (TTM) | $6.61 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $236.14 from 2022-07-01
| 1 week (2022-06-29) | 6.14% |
|---|---|
| 1 month (2022-06-06) | -0.48% |
| 3 months (2022-04-06) | -1.41% |
| 6 months (2022-01-06) | 5.94% |
| 1 year (2021-07-06) | 35.98% |
|---|---|
| 2 years (2020-07-06) | 51.78% |
| 3 years (2019-07-05) | 146.54% |
| 5 years (2017-07-05) | 534.44% |
Valuing Kinsale Capital Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Kinsale Capital Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Kinsale Capital Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Kinsale Capital Group shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Kinsale Capital Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Kinsale Capital Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Kinsale Capital Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $190.7 million.
The EBITDA is a measure of a Kinsale Capital Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $681.8 million |
|---|---|
| Operating margin TTM | 27.61% |
| Gross profit TTM | $164.8 million |
| Return on assets TTM | 6.26% |
| Return on equity TTM | 24.32% |
| Profit margin | 22.35% |
| Book value | $29.06 |
| Market capitalisation | $5.3 billion |
TTM: trailing 12 months
Dividend payout ratio: 7.67% of net profits
Recently Kinsale Capital Group has paid out, on average, around 7.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Kinsale Capital Group shareholders could enjoy a 0.23% return on their shares, in the form of dividend payments. In Kinsale Capital Group's case, that would currently equate to about $0.46 per share.
While Kinsale Capital Group's payout ratio might seem low, this can signify that Kinsale Capital Group is investing more in its future growth.
Kinsale Capital Group's most recent dividend payout was on 12 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 26 May 2022 (the "ex-dividend date").
Over the last 12 months, Kinsale Capital Group's shares have ranged in value from as little as $157.5357 up to $244.8695. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Kinsale Capital Group's is 0.9469. This would suggest that Kinsale Capital Group's shares are less volatile than average (for this exchange).
Kinsale Capital Group, Inc. , a specialty insurance company, provides property and casualty insurance products in the United States. The company's commercial lines offerings include construction, small business, excess and general casualty, commercial property, allied health, life sciences, energy, environmental, health care, inland marine, public entity, and commercial insurance, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U. S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.